WeDaita Science

Research Publications

Peer-reviewed research from our team spanning immunology, genomics, virology, and drug discovery.

  • 1
    IgD+ age-associated B cells are the progenitors of the main T-independent B cell response to infection that generates protective Ab and can be induced by an inactivated vaccine in the aged.
    Kugler-Umana O, Zhang W, Kuang Y, Liang J, Castonguay CH, Tonkonogy SL, Marshak-Rothstein A, Devarajan P, Swain SL.
    Aging Cell 2022 Immunology doi:10.1111/acel.13705
  • 2
    Pathway specific polygenic risk scores identify pathways and patient clusters associated with inflammatory bowel disease risk, severity and treatment response.
    Bodea CA, Macoritto M, Liu Y, Zhang W, Karman J, King EA, Degner JF, Levesque M, Davis JW, Cao S.
    American Journal of Human Genetics (submitted) 2021 Genomics
  • 3
    The properties of the unique age-associated B cell subset reveal a shift in strategy of immune response with age.
    Swain SL, Kugler-Umana O, Kuang Y, Zhang W.
    Cellular Immunology 2017 Immunology
  • 4
    IL-6 Production by TLR-Activated APC Broadly Enhances Aged Cognate CD4 Helper and B Cell Antibody Responses In Vivo.
    Brahmakshatriya V, Kuang Y, Devarajan P, Xia J, Zhang W, Vong AM, Swain SL.
    Journal of Immunology 2017 Immunology
  • 5
    PGE2 Increases Lentiviral Vector Transduction Efficiency of Human HSC.
    Heffner G, Bonner M, Campbell D, Christiansen L, Pierciey FJ, Zhang W, Lewis G, Smurnyy Y, Hamel A, Shah S, Horton H, Ryu B, Goss K, Negre O, Veres G, Horvath C, Finer M, Gregory P.
    Molecular Therapy, Volume 24, S89–S90 2016 Cell Biology
  • 6
    Effector CD4 T cell transition to memory requires late cognate interactions that induce autocrine IL-2.
    McKinstry KK, Strutt T, Bautista B, Zhang W, Kuang Y, Cooper A, Swain SL.
    Nature Communications 2014 Immunology
  • 7
    CD4 T cell defects in the aged: Causes, consequences and strategies to circumvent.
    Zhang W, Brahmakshatriya V, Swain SL.
    Experimental Gerontology 2014 Immunology
  • 8
    Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice.
    Zhang W, Choi Y, Haynes LM, Harcourt JL, Anderson LJ, Jones LP, Tripp RA.
    Journal of Virology, 84, 1148–1157 2010 Virology
  • 9
    The host response and molecular pathogenesis associated with respiratory syncytial virus infection.
    Oshansky CM, Zhang W, Moore E, Tripp RA.
    Future Microbiology, 4, 279–297 2009 Virology
  • 10
    RNA Interference Inhibits Respiratory Syncytial Virus Replication and Disease Pathogenesis without Inhibiting Priming of the Memory Immune Response.
    Zhang W, Tripp RA.
    Journal of Virology, 82, 12221–12231 2008 Virology
  • 11
    Differential roles for cytosolic and microsomal Ca2+-independent phospholipase A2 in cell growth and maintenance of phospholipids.
    Saavedra G, Zhang W, Peterson B, Cummings BS.
    Journal of Pharmacology and Experimental Therapeutics, 318, 1211–1219 2006 Cell Biology
  • 12
    Identification and distribution of endoplasmic reticulum iPLA2.
    Kinsey GR, Cummings BS, Beckett CS, Saavedra G, Zhang W, McHowat J, Schnellmann RG.
    Biochemical and Biophysical Research Communications, 327, 287–293 2005 Cell Biology
  • 13
    AlphaFold3 for Structure-Guided Ligand Discovery
    Menon KM, Davasam A, Chen G, Bryant C, Lam B, Yang C, Barcelos D, et al.
    bioRxiv, 2025.12.04.692352 2025 Drug Discovery
  • 14
    A repurposed drug interferes with nucleic acid to inhibit the dual activities of coronavirus nsp13
    Soper N, Yardumian I, Chen E, Yang C, Ciervo S, Oom AL, Desvignes L, et al.
    ACS Chemical Biology 19 (7), 1593–1603 2024 Drug Discovery
  • 15
    Current Computational Methods for Protein-Peptide Complex Structure Prediction
    Yang C, Xu X, Xiang C.
    Current Medicinal Chemistry 2024 Drug Discovery
  • 16
    Protein–ligand docking in the machine-learning era
    Yang C, Chen EA, Zhang Y.
    Molecules 27 (14), 4568 2022 Drug Discovery
  • 17
    Delta machine learning to improve scoring-ranking-screening performances of protein–ligand scoring functions
    Yang C, Zhang Y.
    Journal of Chemical Information and Modeling 62 (11), 2696–2712 2022 Drug Discovery
  • 18
    De novo Design of SARS-CoV-2 Main Protease Inhibitors
    Fischer C, Vepřek NA, Peitsinis Z, Rühmann KP, Yang C, Spradlin JN, et al.
    Synlett 33 (05), 458–463 2022 Drug Discovery
  • 19
    EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction
    Zhao J, Blayney A, Liu X, Gandy L, Jin W, Yan L, Ha JH, Canning AJ, Yang C, et al.
    Nature Communications 2021 Drug Discovery
  • 20
    Selective and noncovalent targeting of RAS mutants for inhibition and degradation
    Teng KW, Tsai ST, Hattori T, Fedele C, Koide A, Yang C, Hou X, Zhang Y, et al.
    Nature Communications 12 (1), 2656 2021 Drug Discovery
  • 21
    Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis
    Xia Y, Liu Y, Yang C, Simeone DM, Sun TT, DeGraff DJ, Tang M, Zhang Y, et al.
    Nature Communications 12 (1), 2047 2021 Drug Discovery
  • 22
    Lin_F9: A Linear Empirical Scoring Function for Protein–Ligand Docking
    Yang C, Zhang Y.
    Journal of Chemical Information and Modeling 2021 Drug Discovery
  • 23
    Exploring fragment-based target-specific ranking protocol with machine learning on cathepsin S
    Yang Y, Lu J, Yang C, Zhang Y.
    Journal of Computer-Aided Molecular Design 2019 Drug Discovery
  • 24
    Selection and characterization of alanine racemase inhibitors against Aeromonas hydrophila
    Wang Y, Yang C, Xue W, Zhang T, Liu X, Ju J, Zhao B, Liu D.
    BMC Microbiology 17 (1), 122 2017 Drug Discovery
  • 25
    A two-step binding mechanism for the self-binding peptide recognition of target domains
    Yang C, Zhang S, Bai Z, Hou S, Wu D, Huang J, Zhou P.
    Molecular BioSystems 12 (4), 1201–1213 2016 Drug Discovery
  • 26
    Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome
    Zhou P, Zhang S, Wang Y, Yang C, Huang J.
    Journal of Biomolecular Structure and Dynamics 34 (8), 1806–1817 2016 Drug Discovery
  • 27
    Structural and energetic insights into the intermolecular interaction among human leukocyte antigens, clinical hypersensitive drugs and antigenic peptides
    Yang C, Wang C, Zhang S, Huang J, Zhou P.
    Molecular Simulation 41 (9), 741–751 2015 Drug Discovery
  • 28
    Self-binding peptides: folding or binding?
    Yang C, Zhang S, He P, Wang C, Huang J, Zhou P.
    Journal of Chemical Information and Modeling 55 (2), 329–342 2015 Drug Discovery
  • 29
    Mutatomics analysis of the systematic thermostability profile of Bacillus subtilis lipase A
    Tian F, Yang C, Wang C, Guo T, Zhou P.
    Journal of Molecular Modeling 20 (6), 2257 2014 Drug Discovery
  • 30
    Biomacromolecular quantitative structure–activity relationship (BioQSAR): a proof-of-concept study on the modeling, prediction and interpretation of protein–protein binding affinity
    Zhou P, Wang C, Tian F, Ren Y, Yang C, Huang J.
    Journal of Computer-Aided Molecular Design 27 (1), 67–78 2013 Drug Discovery
  • 31
    What are the ideal properties for functional food peptides with antihypertensive effect? A computational peptidology approach
    Zhou P, Yang C, Ren Y, Wang C, Tian F.
    Food Chemistry 141 (3), 2967–2973 2013 Drug Discovery
  • 32
    Computational peptidology: a new and promising approach to therapeutic peptide design
    Zhou P, Wang C, Ren Y, Yang C, Tian F.
    Current Medicinal Chemistry 20 (15), 1985–1996 2013 Drug Discovery